A strong correlation in pathophysiology related to IL-1 and IL-6 and TNF has been established between the two conditions and supplementation of anti-TNF therapy in Crohn's disease patients has resulted in the resolution of HS symptoms [88-90]. Here, TNF is linked to Crohn disease.